Avalo Therapeutics

Avalo is a leading clinical-stage biopharmaceutical company discovering, developing, and commercializing targeted therapies for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Our mission is to transform patients' lives through novel therapies that deliver on the promise of first-in-class medicines. We are united by a commitment to teamwork, a passion for science, and dedication to patients and families affected by serious and rare diseases. Our cross-functional teams possess deep expertise in disease pathology and the clinical development of novel therapeutic targets.